Cancer Research Horizons
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Infinitopes
21 Jan 2026
Infinitopes secures an £11m seed round led by Octopus Ventures and Amplify Bio to prevent recurrence of oesophageal cancer
Infinitopes develops off-the-shelf precision cancer vaccines designed to prevent recurrence, using AI-powered immunomics to target shared tumour features and advance new immunotherapies into clinical trials.
52North
6 Dec 2024
Oncology medical tech startup 52North secures £5m with landmark UK-US hospital VC deal
52North builds medical devices and digital tools that support cancer patients outside hospital, focusing on early detection and monitoring of treatment-related complications to improve urgent oncology care pathways.
Cancer Research Horizons
More venture news
- 27 Jul 2026
etn.ETN unlocks a £1.2m seed round led by Powerhouse Capital to broadcast Europe's first daily live tech news show
SeedMedia & Entertainment - 30 Jul 2026
TaskHerTaskHer lands a £650k seed round led by Trust for London and Resolution Ventures to connecting homeowners with verified tradeswomen
SeedConsumer - 30 Jul 2026
IntropyIntropy lands an £8m seed round led by Felix Capital to automate inventory and pricing decisions for spare parts firms
SeedSupply Chain
